Filing Flows › Thermo Fisher Scientific (TMO) › Capital expenditures
Thermo Fisher Scientific (TMO) capital expenditures by quarter
Thermo Fisher Scientific's capital expenditures were $437M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $294M (Q2 2025) to $465M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $437M | -3% | +8% |
| Q2 2026 | $450M | +20% | +53% |
| Q1 2026 | $376M | -19% | +4% |
| Q4 2025 | $465M | +15% | — |
| Q3 2025 | $404M | +37% | — |
| Q2 2025 | $294M | -19% | — |
| Q1 2025 | $362M | — | — |
Q3 2026 at a glance
Thermo Fisher Scientific, Q3 2026: revenue $12.1B (+9% year over year), operating margin 18.6%, net earnings $1.7B, operating cash flow $2.5B. The chart follows the revenue to costs, profit and cash.
Questions
What is Thermo Fisher Scientific's capital expenditures?
Thermo Fisher Scientific's capital expenditures were $437M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Thermo Fisher Scientific's capital expenditures changed?
Over the last 7 quarters it ranged from $294M (Q2 2025) to $465M (Q4 2025).
Q3 2026 results → · How Thermo Fisher Scientific makes money →